Flt3 ligand treatment modulates parasitemia during infection with rodent malaria parasites via MyD88- and IFN-γ-dependent mechanisms

Parasite Immunology

Volumn 36, Issue 2, 2014, Pages 87-99

  Tamura, T ^a   Akbari, M ^a   Kimura, K ^a   Kimura, D ^a   Yui, K ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

IFN ; Innate immunity; Malaria; Parasitemia

Indexed keywords

CD11B ANTIGEN; FLT3 LIGAND; GAMMA INTERFERON; INTERLEUKIN 12; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE INACTIVATION; INNATE IMMUNITY; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARASITEMIA; PHAGOCYTOSIS; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; SPLEEN CELL;

IFN-Γ; INNATE IMMUNITY; MALARIA; PARASITEMIA;

ANIMALS; FEMALE; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-12; KILLER CELLS, NATURAL; MALARIA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PARASITEMIA; PHAGOCYTOSIS; PLASMODIUM BERGHEI; SPLEEN; TRANSDUCTION, GENETIC;

EID: 84891932068     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12085     Document Type: Article

References (47)

1. Schofield L & Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005; 5: 722-735.
2. + T cells in experimental cerebral malaria. J Immunol 2002; 169: 6369-6375.
3. de Souza JB, Hafalla JC, Riley EM & Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology 2009; 137: 755-772.
4. Amante FH, Haque A, Stanley AC, et al. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol 2010; 185: 3632-3642.
5. Baptista FG, Pamplona A, Pena AC, Mota MM, Pied S & Vigario AM. Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect Immun 2010; 78: 4033-4039.
6. Franke-Fayard B, Fonager J, Braks A, Khan SM & Janse CJ. Sequestration and tissue accumulation of human malaria parasites: can we learn anything from rodent models of malaria? PLoS Pathog 2010; 6: e1001032.
7. Lovegrove FE, Gharib SA, Pena-Castillo L, et al. Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog 2008; 4: e1000068.
8. Del Portillo HA, Ferrer M, Brugat T, Martin-Jaular L, Langhorne J & Lacerda MV. The role of the spleen in malaria. Cell Microbiol 2012; 14: 343-355.
9. Yadava A, Kumar S, Dvorak JA, Milon G & Miller LH. Trafficking of Plasmodium chabaudi adami-infected erythrocytes within the mouse spleen. Proc Natl Acad Sci USA 1996; 93: 4595-4599.
10. McCall MB & Sauerwein RW. Interferon-γ -central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J Leukoc Biol 2010; 88: 1131-1143.
11. Sponaas AM, Freitas do Rosario AP, Voisine C, et al. Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria. Blood 2009; 114: 5522-5531.
12. deWalick S, Amante FH, McSweeney KA, et al. Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J Immunol 2007; 178: 6033-6037.
13. + dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria. Int J Parasitol 2010; 40: 711-719.
14. Pouniotis DS, Proudfoot O, Bogdanoska V, Apostolopoulos V, Fifis T & Plebanski M. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect. Infect Immun 2004; 72: 5331-5339.
15. Shortman K & Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007; 7: 19-30.
16. + dendritic cells in vivo. J Exp Med 2003; 198: 305-313.
17. Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 1996; 184: 1953-1962.
18. McKenna HJ, Stocking KL, Miller RE, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000; 95: 3489-3497.
19. Tamura T, Kimura K, Yuda M & Yui K. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA. Infect Immun 2011; 79: 3947-3956.
20. Shinkai Y, Rathbun G, Lam KP, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992; 68: 855-867.
21. Adachi O, Kawai T, Takeda K, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998; 9: 143-150.
22. Yamamoto M, Sato S, Hemmi H, et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003; 4: 1144-1150.
23. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A & Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993; 259: 1739-1742.
24. Frangogiannis NG, Dewald O, Xia Y, et al. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 2007; 115: 584-592.
25. Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374: 546-549.
26. Shaw SG, Maung AA, Steptoe RJ, Thomson AW & Vujanovic NL. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. J Immunol 1998; 161: 2817-2824.
27. Ishida H, Matsuzaki-Moriya C, Imai T, et al. Development of experimental cerebral malaria is independent of IL-23 and IL-17. Biochem Biophys Res Commun 2010; 402: 790-795.
28. Pichyangkul S, Yongvanitchit K, Kum-arb U, et al. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J Immunol 2004; 172: 4926-4933.
29. Guermonprez P, Helft J, Claser C, et al. Inflammatory Flt3 l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med 2013; 19: 730-738.
30. Matsuzaki-Moriya C, Tu L, Ishida H, et al. A critical role for phagocytosis in resistance to malaria in iron-deficient mice. Eur J Immunol 2011; 41: 1365-1375.
31. Wilson NS, Behrens GM, Lundie RJ, et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 2006; 7: 165-172.
32. Lundie RJ, Young LJ, Davey GM, et al. Blood-stage Plasmodium berghei infection leads to short-lived parasite-associated antigen presentation by dendritic cells. Eur J Immunol 2010; 40: 1674-1681.
33. Dominguez PM & Ardavin C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev 2010; 234: 90-104.
34. Gazzinelli RT & Denkers EY. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 2006; 6: 895-906.
35. Serbina NV, Jia T, Hohl TM & Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008; 26: 421-452.
36. Akira S & Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
37. Coban C, Ishii KJ, Horii T & Akira S. Manipulation of host innate immune responses by the malaria parasite. Trends Microbiol 2007; 15: 271-278.
38. Ing R, Segura M, Thawani N, Tam M & Stevenson MM. Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation. J Immunol 2006; 176: 441-450.
39. Dostert C, Guarda G, Romero JF, et al. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS ONE 2009; 4: e6510.
40. Waskow C, Liu K, Darrasse-Jeze G, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol 2008; 9: 676-683.
41. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M & Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327: 656-661.
42. + T cells. Immunity 2008; 29: 476-486.
43. Ato M, Maroof A, Zubairi S, Nakano H, Kakiuchi T & Kaye PM. Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. J Immunol 2006; 176: 5486-5493.
44. Campanella GS, Tager AM, El Khoury JK, et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci USA 2008; 105: 4814-4819.
45. Miu J, Mitchell AJ, Muller M, et al. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol 2008; 180: 1217-1230.
46. Belnoue E, Costa FT, Vigario AM, et al. Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria. Infect Immun 2003; 71: 3648-3651.
47. + T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS ONE 2011; 6: e18720.